Invasive fungal infections in a pediatric hematology-oncology department: A ۱۶-year retrospective study

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 68

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_CUMM-6-2_007

تاریخ نمایه سازی: 11 آذر 1402

Abstract:

Background and Purpose: Invasive fungal infections (IFIs) are a major cause of morbidity and mortality in immunocompromised children. The purpose of our study was to evaluate the incidence of IFIs in pediatric patients with underlying hematologic malignancies and determine the patient characteristics, predisposing factors, diagnosis, treatment efficacy, and outcome of IFIs. Materials and Methods: For the purpose of the study, a retrospective analysis was performed on cases with proven and probable fungal infections from January ۲۰۰۱ to December ۲۰۱۶ (۱۶ years). Results: During this period, ۲۹۷ children with hematologic malignancies were admitted to the ۲nd Pediatric Department of Aristotle University of Thessaloniki, Greece, and ۲۴ cases of IFIs were registered. The most common underlying diseases were acute lymphoblastic leukemia (ALL; n=۱۹, ۷۹%), followed by acute myeloid leukemia (AML; n=۴, ۱۷%) and non-Hodgkin lymphoma (NHL; n=۱, ۴%). The crude incidence rates of IFIs in ALL, AML, and NHL were ۱۰.۵%, ۱۸.۲%, and ۲.۸% respectively. Based on the results, ۲۵% (n=۶) and ۷۵% (n=۱۸) of the patients were diagnosed as proven and probable IFI cases, respectively. The lung was the most common site of involvement in ۱۶ (۶۶.۷%) cases. Furthermore, Aspergillus and Candida species represented ۵۸.۳% and ۲۹.۱% of the identified species, respectively. Regarding antifungal treatment, liposomal amphotericin B was the most commonly prescribed therapeutic agent (n=۲۱), followed by voriconazole (n=۹), caspofungin (n=۳), posaconazole (n=۳), micafungin (n=۱), and fluconazole (n=۱). In addition, ۱۲ children received combined antifungal treatment. The crude mortality rate was obtained as ۳۳.۳%. Conclusion: As the findings of the present study indicated, despite the progress in the diagnosis and treatment of IFIs with the use of new antifungal agents, the mortality rate of these infections still remains high.

Authors

Nikoleta Kazakou

Hematology-Oncology Unit, ۲nd Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

Timoleon-Achilleas Vyzantiadis

First Department of Microbiology, School of Medicine, Aristotle University of Thessaloniki, Greece

Anastasia Gambeta

Hematology-Oncology Unit, ۲nd Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

Eleni Vasileiou

Hematology-Oncology Unit, ۲nd Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

Eleni Tsotridou

Hematology-Oncology Unit, ۲nd Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

Dimitrios Kotsos

Hematology-Oncology Unit, ۲nd Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

Athina Giantsidi

Hematology-Oncology Unit, ۲nd Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

Anna Saranti

Hematology-Oncology Unit, ۲nd Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

Maria Palabougiouki

Hematology-Oncology Unit, ۲nd Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

Maria Ioannidou

Hematology-Oncology Unit, ۲nd Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

Emmanuil Hatzipantelis

Hematology-Oncology Unit, ۲nd Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

Athanasios Tragiannidis

Hematology-Oncology Unit, ۲nd Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, ...
  • Kriengkauykiat J, Ito JI, Dadwal SS. Epidemiology and treatment approaches ...
  • Pana ZD, Roilides E, Warris A, Groll AH, Zaoutis T. ...
  • Tragiannidis A, Tsoulas C, Kerl K, Groll AH. Invasive candidiasis: ...
  • Beck-Sague CM, Jarvis WR. Secular trends in the epidemiology of ...
  • Edmont MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, ...
  • Martino R, Subira M. Invasive fungal infections in hematology: new ...
  • Tragiannidis A, Fegeler W, Rellensmann G, Debus V, Müller V, ...
  • Athanassiadou F, Tragiannidis A, Kourti M, Papageorgiou T, Velegraki A, ...
  • Tragiannidis A, Roilides E, Walsh TJ, Groll AH. Invasive aspergillosis ...
  • Bartlett AW, Cann MP, Yeoh DK, Bernard A, Ryan AL, ...
  • Wang SS, Kotecha RS, Bernard A, Blyth CC, McMullan BJ, ...
  • Sahbudak Bal Z, Yilmaz Karapinar D, Karadas N, Sen S, ...
  • Yeh TC, Liu HC, Wang LY, Chen SH, Liang DC. ...
  • Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, ...
  • Hope WW, Castagnola E, Groll AH, Roilides E, Akova M, ...
  • De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards ...
  • Kumar J, Singh A, Seth R, Xess I, Jana M, ...
  • Villarroel M, Avilés CL, Silva P, Guzmán AM, Poggi H, ...
  • Mor M, Gilad G, Kornreich L, Fisher S, Yaniv I, ...
  • Hovi L, Saxen H, Saarinen-Pihkala UM, Vettenranta K, Meri T, ...
  • Otto WR, Green AM. Fungal infections in children with haematologic ...
  • Downes KJ, Fisher BT, Zane NR. Administration and dosing of ...
  • Iosifidis E, Papachristou S, Roilides E. Advances in the treatment ...
  • نمایش کامل مراجع